Question 1

What is Fosun International — Fosun Wanbang Pharma Group?

Accepted Answer

Fosun International — Fosun Wanbang Pharma Group is a Entity.

Question 2

How often does Fosun International — Fosun Wanbang Pharma Group appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 8 articles.

Question 3

When was Fosun International — Fosun Wanbang Pharma Group first tracked by Ergen?

Accepted Answer

First tracked on Jul 01, 2026.

Question 4

When was Fosun International — Fosun Wanbang Pharma Group last mentioned in news?

Accepted Answer

Last active on Jul 02, 2026.

Question 5

What is Fosun International — Fosun Wanbang Pharma Group's current news sentiment?

Accepted Answer

Aggregate sentiment score: 70 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Fosun International — Fosun Wanbang Pharma Group in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Fosun International — Fosun Wanbang Pharma Group?

Accepted Answer

Junshi Biosciences licenses roconkibart to Fosun Wanbang (Jul 01, 2026, 8 articles).

Question 8

How did the "Junshi Biosciences licenses roconkibart to Fosun Wanbang" event impact Fosun International — Fosun Wanbang Pharma Group?

Accepted Answer

Fosun International — Fosun Wanbang Pharma Group, a wholly-owned subsidiary of Fosun Pharmaceutical Group, has secured the rights to develop, register, manufacture, and commercialize roconkibart in the Greater China region, enriching its immunology and inflammation portfolio.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.